Director/PDMR Shareholding

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Testudo Fund

Vulpes Life Sciences Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Testudo Fund - 34,492,339 shares

Vulpes Life Sciences Fund - 364,000,000 shares

8

Nature of transaction

Purchase

9

Number of shares acquired

Vulpes Testudo Fund - 31,550,000 shares

10

Percentage of issued class acquired

Vulpes Testudo Fund - 2.44%%

11

Shares disposed

N/A

12

Percentage of issued class disposed

N/A

13/14

Price per share of transactions, and date

Vulpes Testudo Fund

30,000,000 shares @ £0.0175875, 6 June 2013

1,550,000 shares @ £0.0173 , 6 June 2013

15

Total holding following notification and total percentage holding following notification

Vulpes Testudo Fund - 34,492,339 shares

Vulpes Life Sciences Fund - 364,000,000 shares

28.14%

16

Date issuer informed

7 June 2013

23

Any additional information

None

24

Contact name and telephone number

T. Watts, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000